De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Afya Toekomstige groei

Future criteriumcontroles 5/6

Afya zal naar verwachting groeien in winst en omzet met respectievelijk 21% en 9.9% per jaar. De winst per aandeel zal naar verwachting groeien met 19.1% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 20.3% zijn.

Belangrijke informatie

21.0%

Groei van de winst

19.1%

Groei van de winst per aandeel

Consumer Services winstgroei30.4%
Inkomstengroei9.9%
Toekomstig rendement op eigen vermogen20.3%
Dekking van analisten

Good

Laatst bijgewerkt18 Sep 2024

Recente toekomstige groei-updates

Recent updates

Afya: Q2 2024 Was Not Surprising, Still An Opportunity Despite New Info On Market Supply

Aug 29

Here's Why Afya (NASDAQ:AFYA) Has Caught The Eye Of Investors

Aug 29
Here's Why Afya (NASDAQ:AFYA) Has Caught The Eye Of Investors

Is It Time To Consider Buying Afya Limited (NASDAQ:AFYA)?

Aug 15
Is It Time To Consider Buying Afya Limited (NASDAQ:AFYA)?

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Jul 17
Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Afya Limited (NASDAQ:AFYA) Shares Could Be 43% Below Their Intrinsic Value Estimate

Jun 20
Afya Limited (NASDAQ:AFYA) Shares Could Be 43% Below Their Intrinsic Value Estimate

Afya's Results Are Improving And The Market Is Undervaluing It

Jun 06

Do Afya's (NASDAQ:AFYA) Earnings Warrant Your Attention?

May 14
Do Afya's (NASDAQ:AFYA) Earnings Warrant Your Attention?

AFYA: Mr Market Is Mistaken

Apr 29

Is Now The Time To Look At Buying Afya Limited (NASDAQ:AFYA)?

Apr 27
Is Now The Time To Look At Buying Afya Limited (NASDAQ:AFYA)?

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Apr 09
Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Afya Is Performing Well And Is A Buy

Mar 19

Are Investors Undervaluing Afya Limited (NASDAQ:AFYA) By 39%?

Mar 17
Are Investors Undervaluing Afya Limited (NASDAQ:AFYA) By 39%?

Be Wary Of Afya (NASDAQ:AFYA) And Its Returns On Capital

Feb 10
Be Wary Of Afya (NASDAQ:AFYA) And Its Returns On Capital

Afya Limited (NASDAQ:AFYA) Not Lagging Market On Growth Or Pricing

Jan 21
Afya Limited (NASDAQ:AFYA) Not Lagging Market On Growth Or Pricing

Should You Think About Buying Afya Limited (NASDAQ:AFYA) Now?

Jan 03
Should You Think About Buying Afya Limited (NASDAQ:AFYA) Now?

These 4 Measures Indicate That Afya (NASDAQ:AFYA) Is Using Debt Reasonably Well

Dec 07
These 4 Measures Indicate That Afya (NASDAQ:AFYA) Is Using Debt Reasonably Well

Afya (NASDAQ:AFYA) May Have Issues Allocating Its Capital

Nov 02
Afya (NASDAQ:AFYA) May Have Issues Allocating Its Capital

What Does Afya Limited's (NASDAQ:AFYA) Share Price Indicate?

Sep 20
What Does Afya Limited's (NASDAQ:AFYA) Share Price Indicate?

Does Afya (NASDAQ:AFYA) Deserve A Spot On Your Watchlist?

Aug 17
Does Afya (NASDAQ:AFYA) Deserve A Spot On Your Watchlist?

Afya GAAP EPS of R$1.12, revenue of R$598.16M; reaffirms FY22 guidance

Aug 23

White Brook Capital - AFYA Ltd: Cheap Stock, Good Business, Inherent Growth

Jul 28

Afya: Margin And Organic Growth Struggles Remain Top Of Mind

Apr 14

Afya On A Grey Price Area

Dec 25

Afya: The Longer-Term Growth Story Remains Intact

Sep 19

Afya to acquire UNIGRANRIO for R$700M

May 27

Here's Why I Think Afya (NASDAQ:AFYA) Is An Interesting Stock

Apr 04
Here's Why I Think Afya (NASDAQ:AFYA) Is An Interesting Stock

Is Afya Limited's (NASDAQ:AFYA) ROE Of 11% Impressive?

Mar 09
Is Afya Limited's (NASDAQ:AFYA) ROE Of 11% Impressive?

Is Afya (NASDAQ:AFYA) Using Too Much Debt?

Feb 16
Is Afya (NASDAQ:AFYA) Using Too Much Debt?

A Look At The Intrinsic Value Of Afya Limited (NASDAQ:AFYA)

Jan 29
A Look At The Intrinsic Value Of Afya Limited (NASDAQ:AFYA)

The Trends At Afya (NASDAQ:AFYA) That You Should Know About

Jan 12
The Trends At Afya (NASDAQ:AFYA) That You Should Know About

What Type Of Returns Would Afya's(NASDAQ:AFYA) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Dec 24
What Type Of Returns Would Afya's(NASDAQ:AFYA) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Afya BOD approves share buyback program

Dec 23

Afya reports Q3 results

Dec 03

Is Afya Limited's (NASDAQ:AFYA) 10% ROE Strong Compared To Its Industry?

Dec 03
Is Afya Limited's (NASDAQ:AFYA) 10% ROE Strong Compared To Its Industry?

Winst- en omzetgroeiprognoses

NasdaqGS:AFYA - Toekomstschattingen van analisten en financiële gegevens uit het verleden (BRL Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20263,9999521,2271,3766
12/31/20253,6577861,1311,1597
12/31/20243,2846789299505
6/30/20243,0675538931,173N/A
3/31/20242,9704788381,130N/A
12/31/20232,8763867981,044N/A
9/30/20232,7303557591,024N/A
6/30/20232,587337667953N/A
3/31/20232,473356606897N/A
12/31/20222,329374547844N/A
9/30/20222,243352495818N/A
6/30/20222,117329430738N/A
3/31/20221,891245434730N/A
12/31/20211,719223354631N/A
9/30/20211,566235387591N/A
6/30/20211,421257329503N/A
3/31/20211,323300300449N/A
12/31/20201,201292234372N/A
9/30/20201,077285283377N/A
6/30/2020974257234380N/A
3/31/2020878212210343N/A
12/31/2019751154178299N/A
9/30/2019636128137247N/A
6/30/2019522106119156N/A
3/31/201941711093120N/A
12/31/2018334865980N/A
12/31/201721645N/A40N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei AFYA ( 21% per jaar) ligt boven de spaarquote ( 2.5% ).

Winst versus markt: De winst van AFYA ( 21% per jaar) zal naar verwachting sneller groeien dan de US markt ( 15.2% per jaar).

Hoge groeiwinsten: De winst van AFYA zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van AFYA ( 9.9% per jaar) zal naar verwachting sneller groeien dan de markt US ( 8.7% per jaar).

Hoge groei-inkomsten: De omzet van AFYA ( 9.9% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen AFYA zal naar verwachting over 3 jaar hoog zijn ( 20.3 %)


Ontdek groeibedrijven